0.6028
price up icon4.85%   0.0279
after-market Dopo l'orario di chiusura: .62 0.0172 +2.85%
loading

BiomX Inc Borsa (PHGE) Ultime notizie

pulisher
Mar 09, 2025

BiomX’s $12 Million Financing - Global Legal Chronicle

Mar 09, 2025
pulisher
Mar 05, 2025

BiomX Inc. secures $12 million from recent offerings - Investing.com India

Mar 05, 2025
pulisher
Mar 04, 2025

Biomx raises $12M to advance phage therapy for CF infections - Cystic Fibrosis News Today

Mar 04, 2025
pulisher
Feb 27, 2025

BiomX Announces $12M Funding for BX004 Study - TipRanks

Feb 27, 2025
pulisher
Feb 26, 2025

BiomX announces series of financings for aggregate gross proceeds of $12M - MSN

Feb 26, 2025
pulisher
Feb 26, 2025

BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million - GlobeNewswire

Feb 26, 2025
pulisher
Feb 26, 2025

Can BiomX's $12M Financing Push Its Cystic Fibrosis Treatment to the Finish Line? - StockTitan

Feb 26, 2025
pulisher
Feb 18, 2025

BiomX (NYSEMKT:PHGE) Trading Up 22.3% – Still a Buy? - Defense World

Feb 18, 2025
pulisher
Feb 06, 2025

Microbiomes Market to Grow by USD 824.3 Million (2025-2029) with Rising Disease Prevalence Boosting the Market, Report on How AI is Redefining Market LandscapeTechnavio - The Malaysian Reserve

Feb 06, 2025
pulisher
Jan 30, 2025

BiomX (NYSEAMERICAN:PHGE) Stock Price Down 1.3% – What’s Next? - Defense World

Jan 30, 2025
pulisher
Jan 26, 2025

Barclays PLC Has $26,000 Position in BiomX Inc. (NYSEMKT:PHGE) - Defense World

Jan 26, 2025
pulisher
Jan 23, 2025

Phage Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight - GlobeNewswire Inc.

Jan 23, 2025
pulisher
Jan 23, 2025

Phage Therapies Clinical Trial Pipeline Shows Potential - GlobeNewswire

Jan 23, 2025
pulisher
Jan 11, 2025

Barclays PLC Sells 225,000 Shares of BiomX Inc. (NYSEMKT:PHGE) - Defense World

Jan 11, 2025
pulisher
Jan 10, 2025

HC Wainwright Reaffirms Buy Rating for BiomX (NYSEAMERICAN:PHGE) - Defense World

Jan 10, 2025
pulisher
Jan 07, 2025

BiomX (NYSEMKT:PHGE) Stock Price Down 1.3% – Here’s Why - Defense World

Jan 07, 2025
pulisher
Dec 18, 2024

BiomX Inc. Regains Compliance with NYSE American Listing Standards - Defense World

Dec 18, 2024
pulisher
Dec 16, 2024

BiomX regains NYSE compliance - Investing.com

Dec 16, 2024
pulisher
Dec 16, 2024

BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards - The Manila Times

Dec 16, 2024
pulisher
Dec 16, 2024

BiomX Regains NYSE American Listing Compliance After Meeting All Standards - StockTitan

Dec 16, 2024
pulisher
Nov 21, 2024

BiomX (NYSEAMERICAN:PHGE) Stock Price Down 12.2% – Should You Sell? - Defense World

Nov 21, 2024
pulisher
Nov 20, 2024

BiomX (PHGE) 5-Day RSI : 13.43 (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024
pulisher
Nov 16, 2024

BiomX Announces Third Quarter 2024 Financial Results and Clinical Program Updates - Defense World

Nov 16, 2024
pulisher
Nov 15, 2024

Biomx stock plunges to 52-week low, hits $0.61 - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

Biomx stock plunges to 52-week low, hits $0.61 By Investing.com - Investing.com Canada

Nov 15, 2024
pulisher
Nov 15, 2024

BiomX shares hold Buy rating from H.C. Wainwright on Q3 results - Investing.com Canada

Nov 15, 2024
pulisher
Nov 15, 2024

BiomX Inc. (AMEX:PHGE) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 15, 2024

BiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net In - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

BiomX Inc. Reports Q3 2024 Financial Turnaround - TipRanks

Nov 15, 2024
pulisher
Nov 14, 2024

BiomX Inc (PHGE) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

BiomX Inc (PHGE) Reports Q3 2024 Net Income of $9.6 Million Amid Increased R&D and Administrative Expenses - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates - The Manila Times

Nov 14, 2024
pulisher
Nov 14, 2024

BiomX Completes Trial Enrollment, Reports $9.6M Net Income in Q3 Despite Program Delays | PHGE Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 13, 2024

Atopic Dermatitis Drugs Market to Grow by USD 6.2 Billion (2024-2028), Driven by High Prevalence of the Condition, AI-Powered Report Explores Market EvolutionTechnavio - PR Newswire

Nov 13, 2024
pulisher
Nov 13, 2024

BiomX (NYSEMKT:PHGE) Trading 4.6% Higher – Time to Buy? - Defense World

Nov 13, 2024
pulisher
Nov 12, 2024

BiomX to Host Third Quarter 2024 Financial Results Conference Call and Webcast on November 14, 2024 - GlobeNewswire

Nov 12, 2024
pulisher
Nov 01, 2024

Biomx stock plunges to 52-week low of $0.72 amid market challenges By Investing.com - Investing.com South Africa

Nov 01, 2024
pulisher
Nov 01, 2024

Biomx stock plunges to 52-week low of $0.72 amid market challenges - Investing.com India

Nov 01, 2024
pulisher
Oct 25, 2024

Biomx stock plunges to 52-week low, hits $0.87 - Investing.com India

Oct 25, 2024
pulisher
Oct 24, 2024

Biomx stock plunges to 52-week low, hits $0.87 By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 23, 2024

BiomX (NYSEMKT:PHGE) Trading Down 2.3%Here's Why - MarketBeat

Oct 23, 2024
pulisher
Oct 19, 2024

BiomX announces a mandatory unit separation - MSN

Oct 19, 2024
pulisher
Oct 16, 2024

BiomX announces mandatory unit separation - Yahoo Finance

Oct 16, 2024
pulisher
Oct 15, 2024

BiomX Announces a Mandatory Unit Separation - The Manila Times

Oct 15, 2024
$305.39
price down icon 0.55%
$34.30
price down icon 2.03%
$32.68
price down icon 0.52%
$19.19
price down icon 3.62%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Capitalizzazione:     |  Volume (24 ore):